print
Vorinostat for multiple myeloma
- Source agency:
- NHSC
- Date of Submission:
- 25/02/2010
- Date of Printing:
- 09/09/2010
- Technology name:
- MK 0683, Zolinza
- Technology - type(s):
- Drug
- Patient indications:
- Multiple myeloma: refractory – second and/or third line; in combination with bortezomib.